JP2018535696A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018535696A5 JP2018535696A5 JP2018540229A JP2018540229A JP2018535696A5 JP 2018535696 A5 JP2018535696 A5 JP 2018535696A5 JP 2018540229 A JP2018540229 A JP 2018540229A JP 2018540229 A JP2018540229 A JP 2018540229A JP 2018535696 A5 JP2018535696 A5 JP 2018535696A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- represented
- fragment
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022078299A JP7503590B2 (ja) | 2015-10-26 | 2022-05-11 | 遺伝子構築物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1518911.1 | 2015-10-26 | ||
| GB1518911.1A GB2547179A (en) | 2015-10-26 | 2015-10-26 | Genetic construct |
| PCT/GB2016/053319 WO2017072498A1 (en) | 2015-10-26 | 2016-10-25 | Genetic construct |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022078299A Division JP7503590B2 (ja) | 2015-10-26 | 2022-05-11 | 遺伝子構築物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018535696A JP2018535696A (ja) | 2018-12-06 |
| JP2018535696A5 true JP2018535696A5 (enExample) | 2019-11-21 |
| JP7073264B2 JP7073264B2 (ja) | 2022-05-23 |
Family
ID=55130230
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018540229A Active JP7073264B2 (ja) | 2015-10-26 | 2016-10-25 | 遺伝子構築物 |
| JP2022078299A Active JP7503590B2 (ja) | 2015-10-26 | 2022-05-11 | 遺伝子構築物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022078299A Active JP7503590B2 (ja) | 2015-10-26 | 2022-05-11 | 遺伝子構築物 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10342880B2 (enExample) |
| EP (2) | EP3985119A1 (enExample) |
| JP (2) | JP7073264B2 (enExample) |
| KR (1) | KR102819739B1 (enExample) |
| CN (1) | CN108350467B (enExample) |
| AU (1) | AU2016344508B2 (enExample) |
| CY (1) | CY1124588T1 (enExample) |
| DK (1) | DK3368678T3 (enExample) |
| ES (1) | ES2886009T3 (enExample) |
| GB (1) | GB2547179A (enExample) |
| HR (1) | HRP20211407T1 (enExample) |
| HU (1) | HUE056911T2 (enExample) |
| LT (1) | LT3368678T (enExample) |
| MX (1) | MX2018005286A (enExample) |
| PL (1) | PL3368678T3 (enExample) |
| PT (1) | PT3368678T (enExample) |
| RS (1) | RS62460B1 (enExample) |
| RU (1) | RU2734678C2 (enExample) |
| SI (1) | SI3368678T1 (enExample) |
| SM (1) | SMT202100520T1 (enExample) |
| WO (1) | WO2017072498A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2999279A1 (en) | 2015-10-01 | 2017-04-06 | Goleini Inc. | Targeted expression of chloride channels and methods of use thereof |
| GB201705484D0 (en) * | 2017-04-05 | 2017-05-17 | Quethera Ltd | Genetic construct |
| KR20200057051A (ko) * | 2017-09-27 | 2020-05-25 | 시질론 테라퓨틱스, 인크. | 활성 세포를 포함하는 방법, 조성물 및 이식 가능한 요소 |
| MX2020004035A (es) | 2017-10-20 | 2020-11-09 | Res Inst Nationwide Childrens Hospital | Métodos y materiales para terapia génica con nt-3. |
| JP2021507723A (ja) * | 2017-12-05 | 2021-02-25 | ユニバーシティ オブ ワシントンＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｗａｓｈｉｎｇｔｏｎ | 視細胞における治療遺伝子の機能的発現を増強するための組成物および方法 |
| CN108250288A (zh) * | 2018-01-17 | 2018-07-06 | 吉林省农业科学院 | 一种叶绿体表达的脑源性神经营养因子hBDNFb蛋白及其制备方法 |
| CN109022487A (zh) * | 2018-08-15 | 2018-12-18 | 上海市第人民医院 | 一种表达p65的基因载体及其用于治疗视网膜神经节细胞变性的基因治疗药物 |
| US12534739B2 (en) | 2018-10-11 | 2026-01-27 | Decibel Therapeutics, Inc. | AAV1 vectors and uses thereof for treatment of otic indications |
| JP2022514863A (ja) * | 2018-12-19 | 2022-02-16 | ヴェルサメブ アーゲー | タンパク質をコードするｒｎａ |
| WO2020179844A1 (ja) * | 2019-03-04 | 2020-09-10 | 公益財団法人東京都医学総合研究所 | Ｔｒｋ断片をコードする核酸構築物、及びその利用 |
| SG11202108864UA (en) * | 2019-03-06 | 2021-09-29 | Generation Bio Co | Closed-ended dna (cedna) and immune modulating compounds |
| US12649930B2 (en) | 2019-03-27 | 2026-06-09 | Sigilon Therapeutics, Inc. | Compositions, devices, and methods for treating Fabry disease |
| CA3133357A1 (en) * | 2019-03-27 | 2020-10-01 | Sigilon Therapeutics, Inc. | Compositions, devices and methods for factor vii therapy |
| US20230038502A1 (en) | 2019-06-11 | 2023-02-09 | Shire Human Genetic Therapies, Inc. | Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein |
| WO2021011841A1 (en) * | 2019-07-18 | 2021-01-21 | Lysogene | Compositions and methods for the treatment of sanfilippo disease and other disorders |
| RU2719013C1 (ru) * | 2019-09-25 | 2020-04-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Генно-инженерная конструкция для стимуляции посттравматической регенерации периферических нервов |
| JP7713130B2 (ja) | 2019-09-30 | 2025-07-25 | イーライ リリー アンド カンパニー | 遺伝性難聴の処置のためのアデノ随伴ウイルス（ａａｖ）システム |
| WO2021081280A1 (en) | 2019-10-23 | 2021-04-29 | Shire Human Genetic Therapies, Inc. | Adeno-associated virus vectors based gene therapy for hereditary angioedema |
| EP4263614A1 (en) | 2020-12-16 | 2023-10-25 | Takeda Pharmaceutical Company Limited | Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein |
| EP4297800A1 (en) * | 2021-02-26 | 2024-01-03 | Icahn School of Medicine at Mount Sinai | Method for decreasing degeneration of retinal ganglion cells |
| CN116179495B (zh) * | 2022-11-28 | 2025-06-06 | 上海恩凯细胞技术有限公司 | 转基因免疫细胞及其应用 |
| CN118256562A (zh) * | 2022-12-26 | 2024-06-28 | 科辉智药(深圳)新药研究中心有限公司 | 一种用于中枢神经系统疾病治疗的基因序列构建体及其应用 |
| KR20250142340A (ko) | 2023-02-02 | 2025-09-30 | 퀘세라 리미티드 | 재조합 아데노-부속 바이러스 벡터 |
| CN118534135A (zh) * | 2024-06-07 | 2024-08-23 | 中国人民解放军联勤保障部队第九二四医院 | 一种中枢性肥胖抵抗标志物及其检测方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5229500A (en) | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
| US6225282B1 (en) * | 1996-01-05 | 2001-05-01 | Genentech, Inc. | Treatment of hearing impairments |
| WO1998016242A1 (en) * | 1996-10-16 | 1998-04-23 | Regeneron Pharmaceuticals, Inc. | Method of enhancing the delivery of growth factors |
| AU3418199A (en) * | 1998-04-20 | 1999-11-08 | Koninklijke Nederlandse Akademie Van Wetenschappen | Use of viral vectors for treatment of the injured peripheral and central nervoussystem |
| DK1343532T3 (da) * | 2000-12-19 | 2013-07-29 | Res Dev Foundation | Lentivirusvektormedieret genoverførsel og anvendelser deraf |
| US7060429B2 (en) * | 2001-02-22 | 2006-06-13 | University Of Maryland, Baltimore | Treatment of neurodegenerative diseases by altering levels of TrkB isoforms and/or TrkC isoforms |
| FR2906533B1 (fr) * | 2006-09-28 | 2013-02-22 | Pf Medicament | Procede de generation d'anticorps actifs contre un antigene de resistance,anticorps obtenus par ledit procede et leurs utilisations |
| CA2701189C (en) * | 2007-10-11 | 2017-05-16 | Biogen Idec Ma Inc. | Methods for treating pressure induced optic neuropathy, preventing neuronal degeneration and promoting neuronal cell survival via administration of lingo-1 antagonists and trkb agonists |
| US9265843B2 (en) * | 2008-03-27 | 2016-02-23 | The Ohio State University | Treatment of metabolic-related disorders using hypothalamic gene transfer of BDNF and compositions therefor |
| CN103614416B (zh) * | 2013-09-30 | 2016-09-07 | 中国人民解放军第二军医大学东方肝胆外科医院 | 一种携带人穿膜肽p53与GM-CSF基因的重组溶瘤腺病毒及其用途 |
-
2015
- 2015-10-26 GB GB1518911.1A patent/GB2547179A/en not_active Withdrawn
-
2016
- 2016-10-25 HR HRP20211407TT patent/HRP20211407T1/hr unknown
- 2016-10-25 LT LTEPPCT/GB2016/053319T patent/LT3368678T/lt unknown
- 2016-10-25 DK DK16788748.8T patent/DK3368678T3/da active
- 2016-10-25 MX MX2018005286A patent/MX2018005286A/es unknown
- 2016-10-25 SM SM20210520T patent/SMT202100520T1/it unknown
- 2016-10-25 RS RS20211108A patent/RS62460B1/sr unknown
- 2016-10-25 WO PCT/GB2016/053319 patent/WO2017072498A1/en not_active Ceased
- 2016-10-25 CN CN201680062516.6A patent/CN108350467B/zh active Active
- 2016-10-25 RU RU2018115760A patent/RU2734678C2/ru active
- 2016-10-25 US US15/762,089 patent/US10342880B2/en active Active
- 2016-10-25 EP EP21187396.3A patent/EP3985119A1/en not_active Withdrawn
- 2016-10-25 PL PL16788748T patent/PL3368678T3/pl unknown
- 2016-10-25 EP EP16788748.8A patent/EP3368678B1/en active Active
- 2016-10-25 JP JP2018540229A patent/JP7073264B2/ja active Active
- 2016-10-25 PT PT167887488T patent/PT3368678T/pt unknown
- 2016-10-25 KR KR1020187011772A patent/KR102819739B1/ko active Active
- 2016-10-25 SI SI201631325T patent/SI3368678T1/sl unknown
- 2016-10-25 AU AU2016344508A patent/AU2016344508B2/en active Active
- 2016-10-25 ES ES16788748T patent/ES2886009T3/es active Active
- 2016-10-25 HU HUE16788748A patent/HUE056911T2/hu unknown
-
2019
- 2019-06-10 US US16/436,676 patent/US11471539B2/en active Active
-
2021
- 2021-09-06 CY CY20211100785T patent/CY1124588T1/el unknown
-
2022
- 2022-05-11 JP JP2022078299A patent/JP7503590B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018115760A (ru) | Генетическая конструкция | |
| US20220331409A1 (en) | Factor ix gene therapy | |
| JP2019089787A5 (enExample) | ||
| JP2025039615A (ja) | 変異体キャプシドを有するアデノ関連ウイルスビリオンおよびその使用方法 | |
| EP3448437B1 (en) | Evasion of neutralizing antibodies by a recombinant adeno-associated virus | |
| MX2023012410A (es) | Metodos para tratar enfermedades oculares usando variantes de aav2 que codifican aflibercept. | |
| IL273776B1 (en) | Gene therapies for lysosomal disorders | |
| RU2019126509A (ru) | Выделенный модифицированный белок VP1 капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе | |
| UY38881A (es) | Métodos de tratamiento de enfermedades neovasculares oculares utilizando variantes de aav2 que codifican aflibercept | |
| FI3737423T3 (fi) | Koostumuksia ja menetelmiä verkkokalvon häiriöiden hoitoon | |
| JP2023503850A5 (enExample) | ||
| MX2024009478A (es) | Métodos para tratar enfermedades neovasculares oculares con variantes de aav2 que codifican aflibercept | |
| MX2024010002A (es) | Metodo para reducir la fluctuacion del cst en amd neovascular mediante un virus adenoasociado recombinante | |
| TW202033768A (zh) | 腺相關病毒對cln6聚核苷酸的遞送 | |
| MX2022002960A (es) | Metodos para tratar enfermedades neovasculares oculares usando variantes de aav2 que codifican para aflibercept. | |
| CN112029773B (zh) | 编码bdnf的核酸及其应用 | |
| JP2023526892A (ja) | バルデー・ビードル症候群の遺伝子治療 | |
| EP4198047A1 (en) | Fukutin related protein gene transfer increase using modified itr sequences | |
| JP2022522004A5 (enExample) | ||
| HK40119673A (en) | Adeno-associated virus virions with variant capsid and methods of use thereof | |
| HK40077196A (en) | Evasion of neutralizing antibodies by a recombinant adeno-associated virus | |
| KR20240137067A (ko) | 개선된 심장 형질도입 및 간의 탈표적화를 위한 aav 캡시드 | |
| JP2024511851A (ja) | 改変血漿凝固第ｖｉｉｉ因子およびその使用方法 | |
| AR119955A1 (es) | Métodos de tratamiento de enfermedades neovasculares oculares utilizando variantes de aav2 que codifican aflibercept | |
| HK40035863B (en) | Adeno-associated virus virions with variant capsid and methods of use thereof |